Skip to main content

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

RVMD holding history

Revolution Medicines, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RVMD overviewAll 13F holders of RVMDFull Q2 2026 holdings

Shares (Q2 2026)
3,344
Value
$626.3K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of RVMD by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,344$626.3K<0.1%−484−12.6%ReducedHolders
Q1 20263,828$372.3K<0.1%−33−0.9%ReducedHolders
Q4 20253,861$307.5K<0.1%+693+21.9%AddedHolders
Q3 20253,168$147.9K<0.1%+1,996+170.3%AddedHolders
Q2 20251,172$43.1K<0.1%−69−5.6%ReducedHolders
Q1 20251,241$43.9K<0.1%+50+4.2%AddedHolders
Q4 20241,191$52.1K<0.1%−1,264−51.5%ReducedHolders
Q3 20242,455$111.3K<0.1%−496−16.8%ReducedHolders
Q2 20242,951$114.5K<0.1%+170+6.1%AddedHolders
Q1 20242,781$89.6K<0.1%+522+23.1%AddedHolders
Q4 20232,259$64.8K<0.1%+874+63.1%AddedHolders
Q3 20231,385$38.3K<0.1%−190−12.1%ReducedHolders
Q2 20231,575$42.1K<0.1%+638+68.1%AddedHolders
Q1 2023937$20.3K<0.1%+572+156.7%AddedHolders
Q4 2022365$8.69K<0.1%−306−45.6%ReducedHolders
Q3 2022671$13.0K<0.1%+200+42.5%AddedHolders
Q2 2022471$9.00K<0.1%−484−50.7%ReducedHolders
Q1 2022955$25.0K<0.1%+355+59.2%AddedHolders
Q4 2021600$15.0K<0.1%+106+21.5%AddedHolders
Q3 2021494$13.0K<0.1%+71+16.8%AddedHolders
Q2 2021423$14.0K<0.1%+359+560.9%AddedHolders
Q1 202164$3.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.